Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

Earlier in the week, Novartis said it entered into an agreement with Avidity Biosciences, Inc. (NASDAQ:RNA) to acquire the ...

Fintel reports that on October 29, 2025, TD Cowen downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from Buy to Hold. Analyst Price Forecast Suggests 4.10% Upside As of October 29, 2025, ...

The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...

Cells contain a blueprint in the form of DNA that dictates what they can make.This blueprint is converted into a message, or mRNA, which is then ...

Avidity Biosciences (RNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...